Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$0.95 - $1.99 $12,065 - $25,273
-12,700 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$1.74 - $2.33 $7,656 - $10,252
-4,400 Reduced 25.73%
12,700 $3,000
Q2 2021

Aug 11, 2021

BUY
$2.06 - $2.82 $11,948 - $16,355
5,800 Added 51.33%
17,100 $4,000
Q1 2021

May 14, 2021

BUY
$2.35 - $4.01 $26,555 - $45,313
11,300 New
11,300 $6,000
Q4 2020

Feb 16, 2021

SELL
$1.91 - $2.67 $33,616 - $46,992
-17,600 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$1.81 - $5.53 $31,856 - $97,328
17,600 New
17,600 $3,000

Others Institutions Holding GNCA

# of Institutions
1
Shares Held
10K
Call Options Held
0
Put Options Held
0

About GENOCEA BIOSCIENCES, INC.


  • Ticker GNCA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,783,500
  • Description
  • Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...
More about GNCA
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.